Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5‐aminolaevulinic acid photodynamic therapy
暂无分享,去创建一个
[1] G. Carpenter,et al. Visualization of epidermal growth factor receptors in human epidermis. , 1984, The Journal of investigative dermatology.
[2] A. Cooper,et al. The endothelium in psoriasis , 1995, The British journal of dermatology.
[3] P. Kerkhof,et al. Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol , 1996, Archives of Dermatological Research.
[4] J. Moore,et al. Quantitative histological changes in murine tail skin following photodynamic therapy. , 1989, British Journal of Cancer.
[5] CLAUDE C. FRAZIER,et al. PHOTODYNAMIC THERAPY IN DERMATOLOGY , 1996, International journal of dermatology.
[6] K. Svanberg,et al. Superficial blood flow following photodynamic therapy of malignant non–melanoma skin tumours measured by laser Doppler perfusion imaging , 1997, The British journal of dermatology.
[7] D. Ruiter,et al. A new 180-kDa dermal endothelial cell activation antigen: in vitro and in situ characteristics. , 1993, The Journal of investigative dermatology.
[8] J. Barker,et al. Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries , 2001, British Journal of Dermatology.
[9] H. Hönigsmann,et al. Photodynamic therapy of epithelial skin tumours using delta‐aminolaevulinic acid and desferrioxamine , 1995, The British journal of dermatology.
[10] W. Kennedy,et al. Clinical and histologic evaluation of psoriatic plaques treated with a flashlamp pulsed dye laser. , 1996, Journal of the American Academy of Dermatology.
[11] A. Ros,et al. Psoriasis response to the pulsed dye laser , 1996, Lasers in Surgery and Medicine.
[12] I. Braverman,et al. The response of psoriatic epidermis and microvessels to treatment with topical steroids and oral methotrexate. , 1985, The Journal of investigative dermatology.
[13] T. Ruzicka,et al. Aminolevulinic acid: pharmacological profile and clinical indication , 2001, Expert opinion on investigational drugs.
[14] W. Sterry,et al. Treatment of psoriasis by topical photodynamic therapy with polychromatic light , 1994, The Lancet.
[15] R. G. Statius van Eps,et al. Photodynamic therapy of extracellular matrix stimulates endothelial cell growth by inactivation of matrix-associated transforming growth factor-beta. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[16] Jean Kanitakis,et al. Filaggrin expression in normal and pathological skin , 1988, Virchows Archiv A.
[17] I. Braverman,et al. Role of the microcirculation in the treatment and pathogenesis of psoriasis. , 1982, The Journal of investigative dermatology.
[18] M. Stringer,et al. The variable response of plaque psoriasis after a single treatment with topical 5‐aminolaevulinic acid photodynamic therapy , 1997, The British journal of dermatology.
[19] K. König,et al. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo , 2004, Archives of Dermatological Research.
[20] I. Leigh,et al. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. , 1995, The British journal of dermatology.
[21] L. Nanney,et al. Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. , 1986, The Journal of investigative dermatology.
[22] S. Schwartz,et al. Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. , 1986, Science.
[23] J. Kennedy,et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.
[24] S. Ibbotson,et al. UV-B phototherapy clears psoriasis through local effects. , 2002, Archives of dermatology.
[25] P. Van Erp,et al. Immunohistochemical assessment of keratin 16 on paraffin-embedded sections of normal and hyperproliferative skin: monoclonal antibodies Ks8.12 and LL025 in a comparative study , 1999, Archives of Dermatological Research.
[26] G. Stables,et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. , 1999, Acta dermato-venereologica.
[27] Irene M. Leigh,et al. Keratins (Kl6 and Kl7) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro , 1995 .